Patents by Inventor Joana Goncalves

Joana Goncalves has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF ANALYSIS OF 17Q22 POLYMORPHISMS ASSOCIATED WITH CANCER AND USES THEREOF
    Publication number: 20240336979
    Abstract: The invention relates to a method of predicting a subject's likelihood of being diagnosed with a malignant cancer, comprising measuring the relative expression level of a reference allele and an alternative allele of selected cancer risk associated polymorphisms in 17q22 in blood samples.
    Type: Application
    Filed: June 6, 2024
    Publication date: October 10, 2024
    Applicant: UNIVERSIDADE DO ALGARVE
    Inventors: Joana GONÇALVES DE GOUVEIA MAIA XAVIER, Ana Teresa LUÍS LOPES MAIA, Filipa Alexandra OLEIRO ESTEVES RIBEIROS
  • METHODS OF ANALYSIS OF ALLELIC EXPRESSION OF PIK3CA IN CANCER AND USES THEREOF
    Publication number: 20240068046
    Abstract: The invention provides a method of identifying a subset of cancer patients with a poor prognosis, comprising comparing the allelic expression of a mutant and wildtype PIK3CA allele in a patient sample. The invention further teaches the use of drugs targeting the mutant PI3K protein in a subset of patients which are determined to express the a mutant PIK3CA allele above a certain threshold, in addition to a kit, or system with which PIK3CA allelic expression may be assessed.
    Type: Application
    Filed: September 3, 2023
    Publication date: February 29, 2024
    Applicant: UNIVERSIDADE DO ALGARVE
    Inventors: Ana Teresa LUÍS LOPES MAIA, Joana GONÇALVES DE GOUVEIA MAIA XAVIER, Lizelle WINKELSTRÖTER CORREIA, Ramiro Emanuel MAGNO MORGADO
  • ATOPIC DERMATITIS THERAPY WITH KAPPA OPIOID RECEPTOR AGONIST AS ADJUNCT TO TOPICAL CORTICOSTEROID
    Publication number: 20230285497
    Abstract: The invention relates to a method of treatment of atopic dermatitis in a patient, the method includes providing a course of treatment comprising orally administering an effective amount of a kappa opioid receptor agonist (KORA) to the patient and applying an effective amount of a topical corticosteroid (TCS) to an area of the patient affected by the atopic dermatitis.
    Type: Application
    Filed: April 28, 2022
    Publication date: September 14, 2023
    Applicant: Cara therapeutics, Inc.
    Inventors: Joana Goncalves, Kristine E. Nograles, Derek T. Chalmers